The unique features of this paper are:
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
- To our knowledge, this is the largest reported series in minimally invasive surgery in penile cancer
- This is the first attempt to report complications in penile cancer surgery in a systematic way using Clavien-Dindo classification.
- All the data has been collected prospectively
- We have waited for 36 months since commencing to do this procedure to ensure oncological safety before publishing our results.
- In the authors’ experience of transfer from open surgery to minimally invasive, VEILND in penile cancer has had maximal positive impact in the quality of patient care compared to any other urological cancers like Prostate or Bladder cancer.
- Penile cancer is an under researched area due to rarity of disease and lack of centralisation in many countries
Written by: Vivekanandan Kumar
Read the Abstract